Gideon Rubin is news writer for Raw Story, based in Northern California. He is a graduate of San Francisco State University, where he majored in history. He started out covering sports in the Bay Area, and his byline has appeared in The Associated Press, USA Today, The Los Angeles Daily News and The Philadelphia Daily News, among other publications. Before joining Raw Story, he was a local editor at Patch.
The Supreme Court’s 7-2 ruling that at least for now preserves women’s access to an abortion drug in the United States sends a “signal” to lower courts that little appetite exists on the nation’s highest court to ban mifepristone, a legal expert said Friday.
"And it's a signal in part because they might have certain views on abortion. But the case is in this particular posture where there's this issue of standing. Can plaintiffs bring claims do they have to prove that they themselves would be harmed by the drug being on the market. It's a radical position that's been taken by the courts below. So would they really want to flip back a bunch of other Supreme Court precedents to try to take that claim," Goodman said.
"They've sent a signal. The fact that they only had two justices in dissent, Alito and Thomas, which were expected, is a signal to the Fifth Circuit. The fifth circuit is a very conservative court, but now they might be thinking, Okay, if we go in a certain direction of overturning the FDA, we're going to be overturned by the Supreme Court, and the courts don’t like to do that.
"Another prominent legal expert shared that view."
Former U.S. Acting Solicitor General Neal Katyal tweeted “Most significant thing is Alito and Thomas were only ones to dissent. Bodes well for the future and the Texas Judge’s restrictions and those of the Court of Appeals not being upheld, should this case ever reach SCOTUS.”